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Introduction 
 
Alzheimer’s Disease (AD) is an extremely debilitating neurodegenerative disease that causes progressive 
and substantial memory loss, as well as the loss of other necessary cognitive functions.  Despite recent 
advances in medicine that have led to the decrease in death from several other diseases, the death toll 
for Alzheimer’s continues to rise at an alarming rate.  Researches currently consider the pathological 
trademark of AD to be the extracellular aggregation of Amyloid-β peptides and intracellular neurofibrillary 
tangles in the human brain. The clinical demand for safe and efficient brain imaging capabilities continues 
to unfold, and in response, we report the synthesis of various unsymmetrical fluorophores that show 
strong potential for being used as tools to successfully diagnose AD.  We have taken the current industry 
standards for AD diagnostics, Pittsburgh-B and Thioflavin T, and modified them such that they exhibit 
near-infrared fluorescence capabilities as opposed to the current methods that require PET imaging and 
emit harmful ionizing radiation.     
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Method 
 
The primary backbone of these compounds 
is a substituted benzothiazole (Figure 1).  To 
achieve NIR fluorescence capabilities, we 
utilized various systems of conjugation 
bridging a dimethylamino substituent with 
the benzothiazole core using phenyl, 
thiophene (data not shown here), and 4-
methylquinoline (Figure 1). The compounds 
were injected into CD-1 mice and imaged 
using the FLARE imaging system to 
determine their localization and excretion 
patterns.     
 
Results 
 
The proposed compounds were successfully synthesized and purified as determined by UV 
spectrophotometry, 13C and 1H NMR, HPLC and mass spectrometry.  As research progresses, additional 
compounds with a wide array of substituents will be synthesized based on biological feedback.   
 
Discussion/Conclusion 
 
As the harsh effects of Alzheimer’s continue to take its toll, the need for a method of diagnosis becomes 
of the upmost importance.  Unsymmetrical fluorophores derived from benzothiazole analogs have been 
successfully synthesized and show great promise in initial biological studies.  In the future, our 
collaborators at Beth Israel Deaconess Medical Center at Harvard Medical School will test their efficacy in 
both in vitro and in vivo animal models.   
 
Figure 1: Pittsburgh B and Thioflavin T (top left and right 
respectively).  Our proposed synthetic design of a NIR compound 
modified based on Pittsburgh B and Thioflavin T design (Bottom)  
